Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease
CKD stages impact TMAO levels since patients on non-dialysis treatment had lower levels than patients on HD and PD.
Authors
- Marcelo Ribeiro‐Alves (ORCID: https://orcid.org/0000-0002-8663-3364)
- Denise Mafra (ORCID: https://orcid.org/0000-0001-6752-6056)
- Peter Stenvinkel (ORCID: https://orcid.org/0000-0002-8785-4820)
- Drielly Vargas
- Márcia Ribeiro (ORCID: https://orcid.org/0000-0002-4957-3630)
- Julie Ann Kemp (ORCID: https://orcid.org/0000-0001-6739-8832)
- L. Cardozo (ORCID: https://orcid.org/0000-0001-8507-2369)
Institutions
- Universidade Federal do Rio de Janeiro (BR)
- Universidade Federal Fluminense (BR)
- Karolinska Institutet (SE)
Publication Details
- Journal
- Toxins
- Published
- 2024-12-31
- DOI
- https://doi.org/10.3390/toxins17010015
- Citations
- 5
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 1.70